$13.59
0.090.67%
At close: Jun 9, 5:00 PM EST
$13.59
N/A
After Hours: 4:00 PM EST
Trevi Therapeutics Inc Earnings Estimates
TRVINASDAQ
Trevi Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TRVI
Trevi Therapeutics (TRVI) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.11 and quarterly revenue of N/A.
In the most recent quarter (Q1), Trevi Therapeutics reported EPS of $-0.09, missing estimates of $-0.07 by 0.29%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Trevi Therapeutics has averaged an EPS surprise of 0.25% and a revenue surprise of 0.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.110
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Trevi Therapeutics Earnings History
Analyze the earnings history of Trevi Therapeutics using advanced sorting and filters.
Loading calendar...
Trevi Therapeutics (TRVI) Earnings Per Share
The chart below shows Trevi Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Trevi Therapeutics (TRVI) Revenue
The chart below shows Trevi Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Trevi Therapeutics (NASDAQ:TRVI) reporting earnings?
Trevi Therapeutics (TRVI) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Trevi Therapeutics (NASDAQ:TRVI)?
The Actual EPS was $-0.09, which missed the estimate of $-0.07.
What were Trevi Therapeutics’s (NASDAQ:TRVI) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
